EurekaMag.com logo
+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Recurrent Prostate Tumors Receiving Hormonal Therapy Often Contain a Large Number of Genetic Changes



Recurrent Prostate Tumors Receiving Hormonal Therapy Often Contain a Large Number of Genetic Changes



Scandinavian Journal of Urology & Nephrology Supplementum 0(169): 57




(PDF emailed within 1 workday: $29.90)

Accession: 033119145

Download citation: RISBibTeXText



Related references

Analysis of prostate-specific antigen rebound interval in patients with prostate cancer receiving hormonal therapy and external-beam radiation therapy. Clinical Prostate Cancer 3(1): 43-48, 2004

Does hormonal therapy influence sexual function in men receiving 3D conformal radiation therapy for prostate cancer?. International Journal of Radiation Oncology Biology Physics 50(3): 591-595, July 1, 2001

Impact of Androgen Deprivation Therapy on Sexual and Hormonal Function in Patients Receiving Radiation Therapy for Prostate Cancer. Israel Medical Association Journal 18(1): 49-53, 2016

The impact of hormonal therapy on sexual quality of life in men receiving intensity modulated radiation therapy for prostate cancer. Practical Radiation Oncology 5(3): E223-E228, 2016

The effect of short-term estradiol therapy on cognitive function in older men receiving hormonal suppression therapy for prostate cancer. Journal of the American Geriatrics Society 52(2): 269-273, 2004

The effect on toxicity of induction hormonal therapy in prostate cancer patients receiving dose escalated 3D conformal radiation therapy on RTOG 94-06. International Journal of Radiation Oncology Biology Physics 54(2 Supplement): 133-134, 2002

The effect of short-term estradiol therapy on clotting and inflammatory markers in older men receiving hormonal suppression therapy for prostate cancer. Aging Male 11(2): 71-75, 2008

Prostate Stem Cell Antigen Expression in Radical Prostatectomy Specimens Predicts Early Biochemical Recurrence in Patients with High Risk Prostate Cancer Receiving Neoadjuvant Hormonal Therapy. Plos One 11(3): E0151646-E0151646, 2016

Relationship between hot flashes and fatigue in men receiving hormonal therapy for prostate cancer. Journal of Clinical Oncology 23(16_suppl): 8151-8151, 2016

Does adjuvant hormonal therapy improve freedom from biochemical relapse in prostate cancer patients receiving dose-escalated radiation therapy? An analysis of RTOG 94-06. International Journal of Radiation Oncology*Biology*Physics 69(3-supp-S): 0-0, 2007

Initial decline in hemoglobin during neoadjuvant hormonal therapy predicts for early prostate specific antigen failure following radiation and hormonal therapy for patients with intermediate and high-risk prostate cancer. Cancer 95(2): 275-280, 2002

Variation of alpha-methylacyl-CoA racemase expression in prostate adenocarcinoma cases receiving hormonal therapy. Human Pathology 37(9): 1186-1192, 2006

Role of secondary hormonal therapy in the management of recurrent prostate cancer. Urology 62 Suppl 1: 87-94, 2004

Can cochlear implantation improve neurocognition in the aging population?. Clinical Interventions in Aging 13: 701-712, 2018